HEADER TRANSFERASE/TRANSFERASE INHIBITOR 30-JAN-13 4IZY TITLE CRYSTAL STRUCTURE OF JNK1 IN COMPLEX WITH JIP1 PEPTIDE AND 4-{4-[4-(4- TITLE 2 METHANESULFONYL-PIPERIDIN-1-YL)-INDOL-1-YL]-PYRIMIDIN-2-YLAMINO}- TITLE 3 CYCLOHEXAN COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 8; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 1-369; COMPND 5 SYNONYM: MITOGEN-ACTIVATED PROTEIN KINASE 8 ISOFORM JNK1 BETA2, COMPND 6 MITOGEN-ACTIVATED PROTEIN KINASE 8, ISOFORM CRA_D, CDNA FLJ77387, COMPND 7 HIGHLY SIMILAR TO HOMO SAPIENS MITOGEN-ACTIVATED PROTEIN KINASE 8 COMPND 8 (MAPK8), TRANSCRIPT VARIANT 4, MRNA; COMPND 9 EC: 2.7.1.37; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 2; COMPND 12 MOLECULE: C-JUN-AMINO-TERMINAL KINASE-INTERACTING PROTEIN 1; COMPND 13 CHAIN: B; COMPND 14 FRAGMENT: RESIDUES 157-167; COMPND 15 SYNONYM: JIP-1, JNK-INTERACTING PROTEIN 1, ISLET-BRAIN 1, IB-1, JNK COMPND 16 MAP KINASE SCAFFOLD PROTEIN 1, MITOGEN-ACTIVATED PROTEIN KINASE 8- COMPND 17 INTERACTING PROTEIN 1; COMPND 18 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MAPK8, HCG_23734; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 OTHER_DETAILS: CHEMICAL SYNTHESIS KEYWDS KINASE INHIBITOR, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.KUGLSTATTER,A.SHAO REVDAT 2 20-SEP-23 4IZY 1 REMARK SEQADV REVDAT 1 18-DEC-13 4IZY 0 JRNL AUTH L.GONG,X.HAN,T.SILVA,Y.C.TAN,B.GOYAL,P.TIVITMAHAISOON, JRNL AUTH 2 A.TREJO,W.PALMER,H.HOGG,A.JAHAGIR,M.ALAM,P.WAGNER,K.STEIN, JRNL AUTH 3 L.FILONOVA,B.LOE,F.MAKRA,D.ROTSTEIN,L.RAPATOVA,J.DUNN,F.ZUO, JRNL AUTH 4 J.DAL PORTO,B.WONG,S.JIN,A.CHANG,P.TRAN,G.HSIEH,L.NIU, JRNL AUTH 5 A.SHAO,D.REUTER,J.HERMANN,A.KUGLSTATTER,D.GOLDSTEIN JRNL TITL DEVELOPMENT OF INDOLE/INDAZOLE-AMINOPYRIMIDINES AS JRNL TITL 2 INHIBITORS OF C-JUN N-TERMINAL KINASE (JNK): OPTIMIZATION JRNL TITL 3 FOR JNK POTENCY AND PHYSICOCHEMICAL PROPERTIES. JRNL REF BIOORG.MED.CHEM.LETT. V. 23 3565 2013 JRNL REFN ISSN 0960-894X JRNL PMID 23664880 JRNL DOI 10.1016/J.BMCL.2013.04.029 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 48.74 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 3 NUMBER OF REFLECTIONS : 17753 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.239 REMARK 3 R VALUE (WORKING SET) : 0.238 REMARK 3 FREE R VALUE : 0.261 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 962 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.30 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.36 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1268 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 98.39 REMARK 3 BIN R VALUE (WORKING SET) : 0.3150 REMARK 3 BIN FREE R VALUE SET COUNT : 73 REMARK 3 BIN FREE R VALUE : 0.3860 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2674 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 33 REMARK 3 SOLVENT ATOMS : 77 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 52.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 51.63 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.30000 REMARK 3 B22 (A**2) : -0.71000 REMARK 3 B33 (A**2) : 1.01000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.362 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.243 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.182 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 15.608 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.937 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.923 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2773 ; 0.009 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3752 ; 1.087 ; 1.990 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 326 ; 5.293 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 123 ;37.441 ;24.309 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 504 ;15.044 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 15 ;14.813 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 413 ; 0.077 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2063 ; 0.005 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1656 ; 0.530 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2690 ; 1.022 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1117 ; 1.455 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1062 ; 2.511 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 8 A 361 REMARK 3 ORIGIN FOR THE GROUP (A): -9.1176 0.1061 -12.4725 REMARK 3 T TENSOR REMARK 3 T11: 0.0082 T22: 0.0104 REMARK 3 T33: 0.0880 T12: -0.0024 REMARK 3 T13: 0.0251 T23: 0.0009 REMARK 3 L TENSOR REMARK 3 L11: 0.4873 L22: 0.2823 REMARK 3 L33: 0.2145 L12: -0.1333 REMARK 3 L13: 0.3221 L23: -0.0896 REMARK 3 S TENSOR REMARK 3 S11: -0.0098 S12: 0.0014 S13: 0.0151 REMARK 3 S21: 0.0043 S22: 0.0128 S23: 0.0011 REMARK 3 S31: -0.0083 S32: -0.0007 S33: -0.0030 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4IZY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-FEB-13. REMARK 100 THE DEPOSITION ID IS D_1000077421. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-FEB-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL7-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97946 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17753 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 48.740 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 5.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08300 REMARK 200 FOR THE DATA SET : 17.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.36 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.4 REMARK 200 DATA REDUNDANCY IN SHELL : 4.00 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.76300 REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: FOURIER SYNTHESIS REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: PDB ENTRY 1UKH REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.06 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 3350, 0.2 M LISO4, 0.1 M BIS REMARK 280 -TRIS, PH 5.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 30.21300 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 41.01350 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 41.18550 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 41.01350 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 30.21300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 41.18550 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: ONE BIOLOGICAL ASSEMBLY IN ASYMMETRIC UNIT. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1180 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16260 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 SER A 2 REMARK 465 ARG A 3 REMARK 465 SER A 4 REMARK 465 LYS A 5 REMARK 465 ARG A 6 REMARK 465 ASP A 7 REMARK 465 ALA A 173 REMARK 465 ARG A 174 REMARK 465 THR A 175 REMARK 465 ALA A 176 REMARK 465 GLY A 177 REMARK 465 THR A 178 REMARK 465 SER A 179 REMARK 465 PHE A 180 REMARK 465 MET A 181 REMARK 465 MET A 182 REMARK 465 THR A 183 REMARK 465 PRO A 184 REMARK 465 TYR A 185 REMARK 465 VAL A 186 REMARK 465 VAL A 187 REMARK 465 ALA A 282 REMARK 465 ASP A 283 REMARK 465 SER A 284 REMARK 465 GLU A 285 REMARK 465 HIS A 286 REMARK 465 ASN A 287 REMARK 465 LYS A 288 REMARK 465 PRO A 335 REMARK 465 LYS A 336 REMARK 465 ILE A 337 REMARK 465 PRO A 338 REMARK 465 ASP A 339 REMARK 465 LYS A 340 REMARK 465 GLN A 341 REMARK 465 LEU A 342 REMARK 465 ASP A 343 REMARK 465 GLU A 344 REMARK 465 ASP A 362 REMARK 465 LEU A 363 REMARK 465 HIS A 364 REMARK 465 HIS A 365 REMARK 465 HIS A 366 REMARK 465 HIS A 367 REMARK 465 HIS A 368 REMARK 465 HIS A 369 REMARK 465 ARG B 153 REMARK 465 PHE B 163 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 102 -42.30 -138.90 REMARK 500 ARG A 150 -8.13 78.79 REMARK 500 ASP A 151 35.38 -144.28 REMARK 500 GLU A 331 34.90 -150.75 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1J2 A 401 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4HYU RELATED DB: PDB REMARK 900 RELATED ID: 4HYS RELATED DB: PDB DBREF 4IZY A 1 363 UNP A1L4K2 A1L4K2_HUMAN 1 363 DBREF 4IZY B 153 163 UNP Q9UQF2 JIP1_HUMAN 157 167 SEQADV 4IZY HIS A 364 UNP A1L4K2 EXPRESSION TAG SEQADV 4IZY HIS A 365 UNP A1L4K2 EXPRESSION TAG SEQADV 4IZY HIS A 366 UNP A1L4K2 EXPRESSION TAG SEQADV 4IZY HIS A 367 UNP A1L4K2 EXPRESSION TAG SEQADV 4IZY HIS A 368 UNP A1L4K2 EXPRESSION TAG SEQADV 4IZY HIS A 369 UNP A1L4K2 EXPRESSION TAG SEQRES 1 A 369 MET SER ARG SER LYS ARG ASP ASN ASN PHE TYR SER VAL SEQRES 2 A 369 GLU ILE GLY ASP SER THR PHE THR VAL LEU LYS ARG TYR SEQRES 3 A 369 GLN ASN LEU LYS PRO ILE GLY SER GLY ALA GLN GLY ILE SEQRES 4 A 369 VAL CYS ALA ALA TYR ASP ALA ILE LEU GLU ARG ASN VAL SEQRES 5 A 369 ALA ILE LYS LYS LEU SER ARG PRO PHE GLN ASN GLN THR SEQRES 6 A 369 HIS ALA LYS ARG ALA TYR ARG GLU LEU VAL LEU MET LYS SEQRES 7 A 369 CYS VAL ASN HIS LYS ASN ILE ILE GLY LEU LEU ASN VAL SEQRES 8 A 369 PHE THR PRO GLN LYS SER LEU GLU GLU PHE GLN ASP VAL SEQRES 9 A 369 TYR ILE VAL MET GLU LEU MET ASP ALA ASN LEU CYS GLN SEQRES 10 A 369 VAL ILE GLN MET GLU LEU ASP HIS GLU ARG MET SER TYR SEQRES 11 A 369 LEU LEU TYR GLN MET LEU CYS GLY ILE LYS HIS LEU HIS SEQRES 12 A 369 SER ALA GLY ILE ILE HIS ARG ASP LEU LYS PRO SER ASN SEQRES 13 A 369 ILE VAL VAL LYS SER ASP CYS THR LEU LYS ILE LEU ASP SEQRES 14 A 369 PHE GLY LEU ALA ARG THR ALA GLY THR SER PHE MET MET SEQRES 15 A 369 THR PRO TYR VAL VAL THR ARG TYR TYR ARG ALA PRO GLU SEQRES 16 A 369 VAL ILE LEU GLY MET GLY TYR LYS GLU ASN VAL ASP ILE SEQRES 17 A 369 TRP SER VAL GLY CYS ILE MET GLY GLU MET ILE LYS GLY SEQRES 18 A 369 GLY VAL LEU PHE PRO GLY THR ASP HIS ILE ASP GLN TRP SEQRES 19 A 369 ASN LYS VAL ILE GLU GLN LEU GLY THR PRO CYS PRO GLU SEQRES 20 A 369 PHE MET LYS LYS LEU GLN PRO THR VAL ARG THR TYR VAL SEQRES 21 A 369 GLU ASN ARG PRO LYS TYR ALA GLY TYR SER PHE GLU LYS SEQRES 22 A 369 LEU PHE PRO ASP VAL LEU PHE PRO ALA ASP SER GLU HIS SEQRES 23 A 369 ASN LYS LEU LYS ALA SER GLN ALA ARG ASP LEU LEU SER SEQRES 24 A 369 LYS MET LEU VAL ILE ASP ALA SER LYS ARG ILE SER VAL SEQRES 25 A 369 ASP GLU ALA LEU GLN HIS PRO TYR ILE ASN VAL TRP TYR SEQRES 26 A 369 ASP PRO SER GLU ALA GLU ALA PRO PRO PRO LYS ILE PRO SEQRES 27 A 369 ASP LYS GLN LEU ASP GLU ARG GLU HIS THR ILE GLU GLU SEQRES 28 A 369 TRP LYS GLU LEU ILE TYR LYS GLU VAL MET ASP LEU HIS SEQRES 29 A 369 HIS HIS HIS HIS HIS SEQRES 1 B 11 ARG PRO LYS ARG PRO THR THR LEU ASN LEU PHE HET 1J2 A 401 33 HETNAM 1J2 TRANS-4-[(4-{4-[4-(METHYLSULFONYL)PIPERIDIN-1-YL]-1H- HETNAM 2 1J2 INDOL-1-YL}PYRIMIDIN-2-YL)AMINO]CYCLOHEXANOL FORMUL 3 1J2 C24 H31 N5 O3 S FORMUL 4 HOH *77(H2 O) HELIX 1 1 ASN A 63 VAL A 80 1 18 HELIX 2 2 GLN A 117 MET A 121 5 5 HELIX 3 3 ASP A 124 ALA A 145 1 22 HELIX 4 4 LYS A 153 SER A 155 5 3 HELIX 5 5 ALA A 193 LEU A 198 1 6 HELIX 6 6 ASN A 205 GLY A 221 1 17 HELIX 7 7 ASP A 229 GLY A 242 1 14 HELIX 8 8 CYS A 245 LYS A 250 1 6 HELIX 9 9 GLN A 253 GLU A 261 1 9 HELIX 10 10 SER A 270 PHE A 275 1 6 HELIX 11 11 PRO A 276 PHE A 280 5 5 HELIX 12 12 LYS A 290 LEU A 302 1 13 HELIX 13 13 ASP A 305 ARG A 309 5 5 HELIX 14 14 SER A 311 HIS A 318 1 8 HELIX 15 15 HIS A 318 VAL A 323 1 6 HELIX 16 16 ASP A 326 GLU A 331 1 6 HELIX 17 17 THR A 348 MET A 361 1 14 SHEET 1 A 2 PHE A 10 ILE A 15 0 SHEET 2 A 2 SER A 18 LEU A 23 -1 O SER A 18 N ILE A 15 SHEET 1 B 5 TYR A 26 SER A 34 0 SHEET 2 B 5 GLY A 38 ASP A 45 -1 O ALA A 42 N LYS A 30 SHEET 3 B 5 ARG A 50 LEU A 57 -1 O ILE A 54 N CYS A 41 SHEET 4 B 5 TYR A 105 GLU A 109 -1 O ILE A 106 N LYS A 55 SHEET 5 B 5 ASN A 90 PHE A 92 -1 N ASN A 90 O VAL A 107 SHEET 1 C 3 ALA A 113 ASN A 114 0 SHEET 2 C 3 ILE A 157 VAL A 159 -1 O VAL A 159 N ALA A 113 SHEET 3 C 3 LEU A 165 ILE A 167 -1 O LYS A 166 N VAL A 158 SITE 1 AC1 13 ILE A 32 SER A 34 GLY A 35 ALA A 36 SITE 2 AC1 13 GLN A 37 GLY A 38 VAL A 40 LYS A 55 SITE 3 AC1 13 GLU A 109 MET A 111 LEU A 168 THR A 258 SITE 4 AC1 13 ASN A 262 CRYST1 60.426 82.371 82.027 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016549 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012140 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012191 0.00000